F-Star Therapeutics Inc
Change company Symbol lookup
Select an option...
FSTX F-Star Therapeutics Inc
ADN Advent Technologies Holdings Inc
IMCC IM Cannabis Corp
ABGI ABG Acquisition I Corp
BPT BP Prudhoe Bay Royalty Trust
PBT Permian Basin Royalty Trust
SUN Sunoco LP
BP BP PLC
PSX Phillips 66
COP Conocophillips
Go

Health Care : Biotechnology | Small Cap Value
Based in United Kingdom
Company profile

F-star Therapeutics, Inc. is a clinical-stage biopharmaceutical company that is focused on developing immunotherapies to transform the lives of patients with cancer. The Company's FS118 is the lead product candidate, which is in Phase II trial in PD-1/PD-L1 acquired resistance head and neck cancer patients. It is also developing FS222, FS120 and SB 11285 in Phase I clinical trials in patients with advanced cancers. FS222 is focused on patients with tumors that express low levels of PD-L1 and is a tetravalent, bispecific natural antibody (mAb2) bispecific antibody that is designed to target both the costimulatory CD137 receptor and the inhibitory PD-L1 ligand. FS120 is focused to improve checkpoint inhibitor and chemotherapy outcomes and is a mAb2 bispecific antibody that is designed to bind to and stimulate OX40 and CD137. Its product candidate SB 11285 is focused on improving checkpoint inhibition outcomes as an immunotherapeutic compound for the treatment of selected cancers.

Closing Price
$4.33
Day's Change
-1.54 (-26.24%)
Bid
--
Ask
--
B/A Size
--
Day's High
5.93
Day's Low
2.99
Volume
(Heavy Day)
Volume:
5,303,456

10-day average volume:
653,611
5,303,456
  • Prev Close
    5.87
  • Today's Open
    5.93
  • Day's Range
    2.99-5.93
  • Avg Vol (10-day)
    653.6K
  • Last (time)
    3:48p ET 01/26/23
  • Last (size)
    10
  • 52-Wk Range
    2.07 - 6.93
    LowHigh
  • (05/12/22 - 12/28/22)
    109.18%
  • 118.8%
  • Market Cap
    95.4M
  • Shares Outstanding
    22.0M
  • -2.07
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 1.0
  • 43.07
  • (% of float 01/15/23)
    3.24

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.